FEB 14, 2019 7:30 AM PST

Keynote Presentation: A Comparative Approach to Oncology Drug Development: Integrating Canine Models

Speaker

Abstract

Comparative oncology is the study of naturally-occurring cancers in pet animals (mainly dogs) to broaden and deepen our collective understanding of cancers in both companion species and humans. In this presentation, you will learn about the intramural National Cancer Institute’s Comparative Oncology Program (COP) and Comparative Oncology Trials Consortium (COTC), which provide the necessary infrastructure and expertise in comparative oncology trial design and execution to support studies that are designed to advance and inform human cancer drug development. Several specific examples of how the approach has been applied to the development of novel small molecules, biologic agents, immune-oncology approaches will be presented. This presentation will illustrate how integration of comparative oncology studies can inform the process of drug development for human patients, and demonstrate the value of the approach for the drug development community/relevant stakeholders.

Learning Objectives: 

1. The audience will gain an appreciation and understanding of the value of spontaneous cancers that develop naturally in companion animals in studies of cancer biology and therapy;
2. The audience will gain an understanding of how comparative oncology clinical trials are conducted through the NCI’s Comparative Oncology Trials Consortium to address specific drug development questions, which are complementary to the conventional preclinical testing carried out in other animal models and to Phase 1-2 data collected from human patients.


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
DEC 16, 2020 8:00 AM PST
C.E. CREDITS
DEC 16, 2020 8:00 AM PST
Date: December 16, 2020 Time: 8:00am (PST), 11:00am (EST) Molecular imaging of living specimens offers a means to draw upon the growing body of high-throughput molecular data to better under...
MAR 25, 2021 8:00 AM PDT
C.E. CREDITS
MAR 25, 2021 8:00 AM PDT
Date: March 25, 2021 Time: 8:00am (PST), 11:00am (EST) Flow cytometry has expanded to have more users, more data, and multiple instrument types. While this has lead to more quantitative data...
MAR 16, 2021 10:00 AM PDT
C.E. CREDITS
MAR 16, 2021 10:00 AM PDT
Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
FEB 14, 2019 7:30 AM PST

Keynote Presentation: A Comparative Approach to Oncology Drug Development: Integrating Canine Models


Specialty

Animal Models

Animal Research

Animal Sciences

Research

Cancer Research

Life Science

Lab Animals

Animal Behavior

Veterinary Sciences

Cell Biology

Immunology

Cell Culture

Cell

Clinical Research

Therapy

Geography

Europe78%

North America18%

Registration Source

Website Visitors100%

Job Title

Post Doc17%

Student15%

Research Scientist14%

Medical Laboratory Technician11%

Medical Doctor/Specialist8%

Scientist8%

Educator/Faculty6%

Executive5%

Animal Care Lab Technician3%

Biologist3%

Veterinary Technician3%

Clinical Laboratory Scientist2%

Facility/Department Manager2%

Veterinarian2%

QC/QA2%

Lab Management2%

Organization

Academic Institution48%

Hospital12%

Research Institute11%

Clinical Laboratory4%

Pharmaceutical Company4%

Medical School4%

Biotech Company2%

Industrial Company2%

Ambulatory Care2%

Retired1%

Government/public1%

Independent Laboratories1%

Government1%

Manufacturer & Biotech/pharma1%

Other1%


Show Resources
Loading Comments...
Show Resources
Attendees
  • See more